Federico Bardazzi

17PUBLICATIONS
90CO-AUTHORS
AutoimmunityDermatologyDisease surveillancePsychological methodology, design and analysisAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 26, 2026
Long-Term Changes in Complete Blood Count-Derived Inflammatory Indices During Risankizumab Treatment for Psoriasis: A 208-Week Multicenter Real-World Study.

|Jul 28, 2026
Exploring Rare and Atypical Forms of Psoriasis: A Narrative Review.

|Jul 17, 2026
A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome.

|Feb 23, 2026
Toward the definition of moderate psoriasis: an expert opinion.

Antonio Costanzo, Federico Bardazzi, Martina Burlando

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Feb 06, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Claudio Bonifati, Giuseppe Argenziano, Serena Lembo

Pageof 3

Frequent Collaborators

6 joint publications

Michelangelo La Placa

5 joint publications

Giacomo Clarizio

4 joint publications

Filippi Federica

4 joint publications

Lidia Sacchelli